Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
704 (USA) · Dr. Tanaka
consented 2013-10-12
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild FLATULENCE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-27 (study day 16.0); relationship: NONE
mild
assessed
Mild FLATULENCE — outcome: RECOVERED/RESOLVED; onset 2013-10-27 (study day 16.0); relationship: NONE
mild
assessed
Mild POLLAKIURIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-27 (study day 16.0); relationship: NONE
mild
assessed
Mild POLLAKIURIA — outcome: RECOVERED/RESOLVED; onset 2013-10-27 (study day 16.0); relationship: NONE
Data queries
No data queries.